Clinical application of immunosuppressive agents in renal transplantation

Surgical Clinics of North America

Volumn 78, Issue 1, 1998, Pages 61-76

  First, M R ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

CLINICAL PROTOCOL; CORTICOSTEROID THERAPY; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW;

EID: 0031884034     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70635-6     Document Type: Article

References (32)

1. P. Anderson T.J. Schroeder S. Hariharan Incidence of post-transplant lymphoproliferative disease in OKT3 treated renal transplant recipients Clin Transplant 7 1993 582
2. G.P. Basadonna A.J. Matas K.J. Gillingham Early versus late acute renal allograft rejection: Impact on chronic rejection Transplantation 55 1993 993
3. J.M. Cecka P.I. Terasaki Early rejection episodes Terasaki P.I. Clinical Transplants, 1989 1990 UCLA Tissue Typing Laboratory Los Angeles 425
4. I. Dawidson P. Rooth W. Fry Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil Transplantation 48 1989 575
5. M. El-Ghoroury S. Hariharan V.R. Peddi Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients Transplant Proc 29 1997 649
6. European Mycophenolate Mofetil Cooperative Study Group Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection Lancet 345 1995 1321
7. R.M. Ferguson A multicenter experience with sequential ALG/cyclosporine therapy in renal transplantation Clin Transplant 2 1988 285
8. R.S. Filo E.J. Smith S.B. Leapman Therapy of acute renal allograft rejection with adjunctive antithymocyte globulin Transplantation 30 1980 444
9. M.R. First An update on new immunosuppressive drugs undergoing preclinical and clinical trials: Potential applications in organ transplantation Am J Kidney Dis 29 1997 303
10. FK506 Kidney Transplant Study Group A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric kidney transplantation Transplantation 63 1997 977
11. S. Hariharan T.J. Schroeder P. Weiskittel Prednisone withdrawal in HLA identical and one haplotype–matched live-related donor and cadaver renal transplant recipients Kidney Int 44 1993 S30
12. D.E. Hricik W.Y. Almawi T.B. Strom Trends in the use of glucocorticoids in renal transplantation Transplantation 57 1994 979
13. B.D. Kahan J. Dunn C. Fitts Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low fat meals, or high fat meals Transplantation 59 1995 505
14. A. Lindholm S. Ohlman D. Albrechtsen The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by three cyclosporine regimens Transplantation 56 1993 307
15. R. Manez A. Jain I.R. Marino Comparative evaluation of tacrolimus (FK506) and cyclosporin A as immunosuppressive agents Transplant Rev 9 1995 63
16. A.J. Matas V.A. Tellis T. Quinn ALG treatment of steroid-resistant rejection in patients receiving cyclosporine Transplantation 41 1986 579
17. M. Moran M. Mozes M. Maddux Prevention of acute graft rejection by the prostaglandin E analogue misoprostol in renal transplant recipients treated with cyclosporine and prednisone N Engl J Med 322 1990 1183
18. R.E. Morris Mechanism of action of new immunosuppressive drugs Kidney Int 49 1996 S26
19. Mycophenolate Mofetil Renal Refractory Rejection Study Group Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection Transplantation 61 1996 722
20. J.S. Najarian K.J. Gillingham D.E.R. Sutherland The impact of the quality of initial graft function on cadaver kidney transplants Transplantation 57 1994 812
21. D.J. Norman J.M. Barry W.M. Bennett The use of OKT3 in cadaveric renal transplantation that is unresponsive to conventional antirejection therapy Am J Kidney Dis 11 1988 90
22. Ortho Multicenter Study Group A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants N Engl J Med 313 1985 337
23. G.D. Park M. Bartucci M.C. Smith High- versus low-dose methylprednisolone for acute rejection episodes in renal transplantation Nephron 36 1984 80
24. T.J. Schroeder M.R. First Monoclonal antibodies in organ transplantation Am J Kidney Dis 23 1994 138
25. T.J. Schroeder M.A. Weiss R.D. Smith The efficacy of OKT3 in vascular rejection Transplantation 51 1991 312
26. N.R.St.C. Sinclair Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts Can Med Assoc J 147 1992 613
27. K. Solez R.A. Axelsen H. Benediktsson International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology Kidney Int 44 1993 411
28. Tacrolimus Pancreas Transplant Study Group Tacrolimus in pancreas transplantation: A multicenter analysis Clin Transplant 11 1997 299
29. P.I. Terasaki J.M. Cecka E. Lim Overview Terasaki P.I. Clinical Transplants, 1991 1992 UCLA Tissue Typing Laboratory Los Angeles 409
30. R.J. Tesi M.L. Henry E.A. Elkhammas Predictors of long-term primary cadaveric renal transplant survival Clin Transplant 7 1993 345
31. Tricontinental Mycophenolate Mofetil Renal Transplant Study Group A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation 61 1996 1029
32. United States Renal Transplant Mycophenolate Mofetil Study Group Mycophenolate mofetil for prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 60 1995 225